Zoetis Appoints Jamie Brannan to Newly Created Chief Commercial Officer Role
Zoetis (NYSE:ZTS) has announced major leadership changes, including the appointment of Jamie Brannan as Chief Commercial Officer in a newly created role overseeing all commercial markets globally. The restructuring aims to accelerate long-term growth and optimize global operations. Additional changes include Wafaa Mamilli's planned departure in early 2025, with Keith Sarbaugh promoted to EVP and Chief Digital & Technology Officer. Ester Banque will transition out of her role as EVP and President of U.S. Operations, with Jared Shriver promoted to President, U.S. Operations.
Zoetis (NYSE:ZTS) ha annunciato importanti cambiamenti nella leadership, tra cui la nomina di Jamie Brannan a Chief Commercial Officer in un nuovo ruolo che supervisionerà tutti i mercati commerciali a livello globale. La ristrutturazione mira ad accelerare la crescita a lungo termine e a ottimizzare le operazioni globali. Altri cambiamenti includono la partenza programmata di Wafaa Mamilli all'inizio del 2025, con Keith Sarbaugh promosso a EVP e Chief Digital & Technology Officer. Ester Banque passerà da vicepresidente e presidente delle operazioni statunitensi, mentre Jared Shriver sarà promosso a presidente delle operazioni negli Stati Uniti.
Zoetis (NYSE:ZTS) ha anunciado cambios importantes en su liderazgo, incluyendo el nombramiento de Jamie Brannan como Chief Commercial Officer en un nuevo rol que supervisará todos los mercados comerciales a nivel global. La reestructuración tiene como objetivo acelerar el crecimiento a largo plazo y optimizar las operaciones globales. Otros cambios incluyen la salida planificada de Wafaa Mamilli a principios de 2025, con Keith Sarbaugh ascendido a EVP y Chief Digital & Technology Officer. Ester Banque hará la transición de su rol como EVP y presidenta de Operaciones en EE. UU., mientras que Jared Shriver será promovido a presidente de Operaciones en EE. UU.
Zoetis (NYSE:ZTS)는 주요 경영진 변화를 발표했으며, Jamie Brannan을 글로벌 모든 상업 시장을 감독하는 새로 창설된 직책인 최고 상업 책임자로 임명했습니다. 이번 구조조정은 장기 성장 가속화 및 글로벌 운영 최적화를 목표로 하고 있습니다. 추가 변경 사항으로는 Wafaa Mamilli의 2025년 초 예정된 퇴사와 Keith Sarbaugh의 EVP 및 최고 디지털·기술 책임자로의 승진이 포함됩니다. Ester Banque는 미국 운영 부사장직에서 물러나게 되며, Jared Shriver는 미국 운영 부사장으로 승진합니다.
Zoetis (NYSE:ZTS) a annoncé d'importants changements de direction, y compris la nomination de Jamie Brannan en tant que directeur commercial dans un nouveau rôle qui supervisera tous les marchés commerciaux à l’échelle mondiale. La restructuration vise à accélérer la croissance à long terme et à optimiser les opérations mondiales. D'autres changements comprennent le départ prévu de Wafaa Mamilli début 2025, avec Keith Sarbaugh promu EVP et directeur numérique et technologique. Ester Banque se retirera de son rôle de VP et présidente des opérations aux États-Unis, avec Jared Shriver promu président des opérations aux États-Unis.
Zoetis (NYSE:ZTS) hat wesentliche Veränderungen in der Führungsriege angekündigt, darunter die Ernennung von Jamie Brannan zum Chief Commercial Officer in einer neu geschaffenen Rolle, die alle kommerziellen Märkte weltweit überwacht. Die Umstrukturierung zielt darauf ab, das langfristige Wachstum zu beschleunigen und die globalen Abläufe zu optimieren. Zu den weiteren Änderungen gehört der geplante Abgang von Wafaa Mamilli Anfang 2025, während Keith Sarbaugh zum EVP und Chief Digital & Technology Officer befördert wird. Ester Banque wird ihre Rolle als EVP und Präsidentin der US-Operationen verlassen, während Jared Shriver zum Präsidenten der US-Operationen befördert wird.
- Creation of new Chief Commercial Officer role to optimize global operations
- Strategic restructuring aimed at accelerating long-term growth
- Smooth transition period planned with departing executives staying until early 2025
- Internal promotion of experienced leaders demonstrating strong succession planning
- Departure of key executive Wafaa Mamilli, leader of technology and digital transformation
- Loss of U.S. Operations President Ester Banque who delivered above-market performance
New Commercial Organizational Structure to Accelerate Long-Term Growth Strategy in Key Markets and Optimize Global Commercial Operations
PARSIPPANY, N. J.--(BUSINESS WIRE)-- Zoetis Inc. (NYSE:ZTS) today announced the appointment of Jamie Brannan to a newly created role of Chief Commercial Officer, overseeing all commercial markets across the globe for the world’s leading animal health company. In this new role, Mr. Brannan will lead an evolved commercial organizational structure that will accelerate the company’s long-term growth strategy across key markets, drive greater global commercial collaboration and unlock future growth opportunities.
As Chief Commercial Officer at Zoetis, Jamie Brannan will lead an evolved commercial organizational structure that will accelerate the company’s long-term growth strategy across key markets and optimize global commercial operations. (Photo: Business Wire)
Mr. Brannan, who is currently Executive Vice President and Group President International Operations, Aquaculture and Global Diagnostics, will assume his new role effective immediately. His expanded role includes oversight of commercial operations across
“As we enter the next phase of accelerated growth driven by our innovative and market-leading portfolio, the creation of this role will optimize our commercial operations and best position Zoetis to identify and capitalize on new market opportunities and deliver an exceptional experience for our customers,” said Kristin Peck, Chief Executive Officer of Zoetis. “Jamie is a true enterprise leader who has built high-performing and customer-obsessed leaders and teams. I am confident that Jamie will help Zoetis drive our next phase of growth and continue to deliver excellent performance across markets.”
Mr. Brannan said, “Taking on this new role as Chief Commercial Officer is an incredible honor. I’m excited to lead our global commercial teams as we continue to innovate and deliver outstanding value to our customers. Together, we’ll drive Zoetis’ growth strategy, enhance our market presence and ensure we remain at the forefront of animal health solutions worldwide.”
Additional Leadership Changes
At the same time, Zoetis is announcing the following additional leadership changes:
-
Wafaa Mamilli, currently Executive Vice President, Chief Digital & Technology Officer and Group President for
China ,Brazil and Precision Animal Health, has informed the company of her decision to leave the organization in early 2025 to pursue an external opportunity. The company regrets her decision but is grateful she will remain at Zoetis until early 2025 to ensure a smooth transition. Since joining Zoetis in 2020, Ms. Mamilli has been instrumental in positioning Zoetis as a leader in technology, digital transformation, data analytics and AI within healthcare. She has also overseen two key international markets,China andBrazil , and the company’s precision animal health businesses with a relentless focus on advancing customer success and innovation. - With Ms. Mamilli’s planned departure, Keith Sarbaugh has been promoted to Executive Vice President and Chief Digital & Technology Officer and will join the Zoetis Executive Team, effective immediately. In this role, Mr. Sarbaugh will be responsible for the company’s technology, digital, data and analytics strategy and continue to oversee its Customer Experience function. Mr. Sarbaugh joined Zoetis in March 2023, and previously served as Vice President and Chief Information Officer. He brings nearly 25 years of tech and digital leadership experience from roles in IT and Commercial teams at Biogen and Eli Lilly.
-
Ester Banque, currently Executive Vice President and President,
U.S. Operations, will transition out of her role and pursue other opportunities outside of Zoetis. The company is grateful for Ms. Banque’s contributions to Zoetis during her tenure, delivering above market performance in theU.S. business. She will serve in an advisory capacity until early 2025 to ensure a smooth transition. -
Jared Shriver has been promoted to President,
U.S. Operations, effective immediately, reporting to Mr. Brannan. In his nearly 20-year tenure at Zoetis, Mr. Shriver has demonstrated exceptional leadership across various commercial roles within the organization. He has consistently driven performance, exceeding financial targets and fostering a culture of accountability, collaboration, and excellence in sales and marketing. Mr. Shriver most recently served as Senior Vice President ofU.S. Livestock, Bio Devices, Equine, and Platinum Performance.
About Jamie Brannan
As a senior business leader in human and animal health for over a decade, Mr. Brannan has consistently demonstrated his ability to build diverse teams with the agility to adjust through fast, evolving business conditions across international markets. Since joining Zoetis in 2016, Mr. Brannan has demonstrated a proven track record of strong commercial leadership, disciplined financial performance and the development of high-performing teams.
He most recently served as Executive Vice President and Group President International Operations, Aquaculture and Global Diagnostics at Zoetis, with responsibility for commercial operations in over 100 international markets, the global aquaculture and diagnostic businesses. Previously, he was president, Zoetis International Operations from June 2021 until November 2022, and senior vice president of Zoetis’ Northern Europe Cluster from October 2016 until June 2021.
About Zoetis
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of
ZTS-COR
View source version on businesswire.com: https://www.businesswire.com/news/home/20241111827005/en/
Media Contacts:
Jennifer Albano
1-862-399-0810 (o)
jennifer.albano@zoetis.com
Laura Panza
1-973-975-5176 (o)
laura.panza@zoetis.com
Investor Contacts:
Steve Frank
1-973-822-7141 (o)
steve.frank@zoetis.com
Nick Soonthornchai
1-973-443-2792 (o)
nick.soonthornchai@zoetis.com
Source: Zoetis Inc.
FAQ
What is Jamie Brannan's new role at Zoetis (ZTS)?
Who is replacing Wafaa Mamilli at Zoetis (ZTS)?
Who is the new President of U.S. Operations at Zoetis (ZTS)?
When will the leadership changes at Zoetis (ZTS) take effect?
